tldrdailynews.com logo
Tag

Nice

All articles tagged with #nice

Crawley widow urges NHS to fund life-extending cancer drug
health4 days ago

Crawley widow urges NHS to fund life-extending cancer drug

The husband of Crawley woman Fionnuala Quinlan-Bennett, who died at 32 from breast cancer that spread to her bones and liver, is calling on NHS England and NICE to fund the drug Enhertu. Breast Cancer Now says making Enhertu available on the NHS could help about 1,000 English women. NICE had previously deemed the treatment not cost-effective, but discussions are resuming after a higher cost‑effectiveness threshold was introduced following a US-UK trade deal, with the aim of reaching a commercial agreement to enable access.

via BBC|
#breast-cancer#drug-access#enhertu
Spit test could slash years-long endometriosis diagnosis wait
health1 month ago

Spit test could slash years-long endometriosis diagnosis wait

A saliva-based test called Endotest detects microRNAs in spit to signal endometriosis, potentially shortening the typical diagnosis wait from as long as 11 years. In the UK, NICE has approved its use in clinician offices for three years, though it is not a stand-alone diagnostic tool. The test aims to speed diagnosis, enable earlier treatment, and reduce invasive procedures for a condition that affects about 1 in 10 women worldwide.

via New York Post|
#diagnosis#endometriosis#endotest
NHS to speed up endometriosis diagnosis with two rapid tests
health2 months ago

NHS to speed up endometriosis diagnosis with two rapid tests

NICE approves two non-invasive tests—Endotest and EndoSure—for rapid endometriosis diagnosis on the NHS in England and Wales, with a three-year draft approval to gather more evidence. Endotest uses a saliva test for microRNAs; EndoSure measures gut electrical activity to produce results in about 45 minutes. A third test, DotEndo, needs more research. Intended for patients where suspicion remains after normal exams or inconclusive imaging, these tests aim to cut the typical multi-year diagnostic delay and speed access to treatment.

via The Guardian|
#diagnostics#endometriosis#health
NHS rolls out teplizumab to delay the onset of type 1 diabetes
health2 months ago

NHS rolls out teplizumab to delay the onset of type 1 diabetes

England and Wales will offer teplizumab, the first treatment shown to delay onset of type 1 diabetes by around three years, given as 14 days of IV infusions before symptoms. NICE estimates about 1,100 adults and children could be eligible in the first year, with a confidential NHS discount on the roughly £150,000-per-course price. The drug requires evidence of pre-symptomatic immune attack on the pancreas; routine UK screening remains unavailable. Scotland and Northern Ireland have separate processes, with Scotland’s SMC expected to issue advice in 2027.

via BBC|
#health#immunotherapy#nhs
Ivory Coast forward Elye Wahi under investigation for alleged spot-fixing ahead of World Cup
sports2 months ago

Ivory Coast forward Elye Wahi under investigation for alleged spot-fixing ahead of World Cup

Ivory Coast forward Elye Wahi, 23, was arrested in May as part of an ongoing probe into alleged spot-fixing and betting-related corruption. He has not been charged, and the Marseille prosecutor’s office says the investigation into organized fraud and sports corruption continues. Wahi traveled to the U.S. and played Ivory Coast’s World Cup opener against Ecuador, which the Elephants won 1-0.

via CBS Sports|
#elye-wahi#ivory-coast#nice
Wahi Under Spot-Fixing Inquiry as Ivory Coast Ready for World Cup
sports2 months ago

Wahi Under Spot-Fixing Inquiry as Ivory Coast Ready for World Cup

Ivory Coast forward Elye Wahi was arrested in France as part of an ongoing probe into alleged spot-fixing and money laundering tied to a May Nice vs. Metz match. He was released after police custody and has traveled with Ivory Coast to the World Cup, with authorities saying the investigation remains ongoing and no charges have been filed; FIFA has not indicated any impact on his World Cup eligibility.

via The New York Times|
#ivory-coast#ligue-1#nice
GLP-1 injections reshape the UK's obesity fight
health3 months ago

GLP-1 injections reshape the UK's obesity fight

GLP-1 weight‑loss injections, notably Wegovy and Mounjaro, are transforming obesity treatment in the UK and globally, delivering significant weight loss in trials and real life, but NHS access remains tightly restricted by cost under NICE criteria, prompting concerns about inequality and a growing private market; with more than 50 obesity drugs in trials and new forms like tablets on the horizon, experts expect broader options that could reduce surgery needs while underscoring the importance of addressing underlying causes.

via BBC|
#glp-1#health#nhs
France’s National Rally Bets on Momentum After Mixed Local Elections
politics5 months ago

France’s National Rally Bets on Momentum After Mixed Local Elections

France’s far-right National Rally claimed momentum for the 2027 presidential race after a mixed local-vote night, with wins in Nice and several southern towns but failures to capture marquee cities like Marseille, Toulon and Nîmes; leader Jordan Bardella hailed a “biggest breakthrough” and ongoing local implantation, while critics warned that runoff dynamics could still block a national breakthrough, as polls put Bardella ahead in the first round (about 35%) and traditional parties race to unite against the extremes.

via politico.eu|
#french-local-elections-2026#jordan-bardella#marine-le-pen
NHS adds non-hormonal option for menopausal hot flashes
health6 months ago

NHS adds non-hormonal option for menopausal hot flashes

England's NHS will offer Veoza (fezolinetant) as a non-hormonal treatment for menopausal hot flushes and night sweats when HRT cannot be used; NICE says it’s cost-effective and could help up to 500,000 women. Not recommended for those with breast cancer, other estrogen‑dependent cancers, or liver disease; HRT remains the first-line option. The decision applies in England; Wales and Northern Ireland often follow NICE guidance, while Scotland has not yet recommended NHS use.

via BBC|
#fezolinetant#health#hrt
Experts Warn of Unnecessary Overtreatment for Men with Prostate Cancer
health1 year ago

Experts Warn of Unnecessary Overtreatment for Men with Prostate Cancer

Experts warn that outdated guidelines may lead to unnecessary overtreatment of up to 5,000 men annually with prostate cancer in England, risking serious side effects. The charity Prostate Cancer UK calls for NICE to update its guidance to better reflect recent advances in testing and diagnosis, promoting active surveillance for low-risk cases to prevent harm and reduce the 'postcode lottery' in treatment approaches.

via The Independent|
#active-surveillance#guidelines#health
NHS urged to support weight-loss jab users for a year post-treatment
health1 year ago

NHS urged to support weight-loss jab users for a year post-treatment

The National Institute for Health and Care Excellence (NICE) recommends providing structured support for up to a year after stopping weight-loss medications like Mounjaro or Wegovy to prevent weight regain, emphasizing long-term behavioral habits and community support, especially for NHS patients, while highlighting the role of pharmacies in ongoing weight management efforts.

via The Times|
#health#nice#obesity
French Authorities Link Recent Riviera Blackouts to Sabotage
world1 year ago

French Authorities Link Recent Riviera Blackouts to Sabotage

Two anarchist groups in France claimed responsibility for a power outage that affected over 160,000 homes in Nice and surrounding areas, including the Cannes Film Festival, through arson attacks on electrical infrastructure. The incident caused disruptions to vital services, but power was restored within hours, and authorities are increasing security around electrical sites.

via Euronews.com|
#anarchist-groups#cannes-film-festival#france
NHS Limits Initial Access to Lilly's Mounjaro for Obesity Treatment
health1 year ago

NHS Limits Initial Access to Lilly's Mounjaro for Obesity Treatment

The NHS in England plans to roll out the weight-loss drug Mounjaro, but it may take up to 12 years for full implementation due to concerns about overwhelming healthcare services. The drug, recommended by NICE, will initially be available to those with a BMI over 35 and an obesity-related health issue. The phased rollout aims to prioritize those with the highest clinical need, with an estimated 220,000 people benefiting in the first three years. The decision has sparked disappointment among patient groups due to the lengthy timeline.

via BBC.com|
#health#mounjaro#nhs
UK to Offer Eli Lilly's Mounjaro Weight-Loss Drug on NHS
health2 years ago

UK to Offer Eli Lilly's Mounjaro Weight-Loss Drug on NHS

Britain's medical costs regulator, NICE, has recommended Eli Lilly's weight-loss drug Mounjaro for certain obese patients without a time limit on its use, unlike Novo Nordisk's Wegovy. The draft roadmap suggests Mounjaro for patients with a BMI of at least 35 and one weight-related co-morbidity, with a review if less than 5% weight loss occurs after 6 months. The final decision is expected on October 30 after public comments.

via Reuters|
#health#mounjaro#nhs